Dashboard
Manage Tickers

BIVI BIOVIE INC.

Nasdaq bioviepharma.com


$ 1.88 $ -0.01 (-0.53 %)    

Friday, 24-Oct-2025 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.20 $ 6.52 (1.07 %)
DIA $ 472.05 $ 4.92 (1.05 %)
SPY $ 677.01 nm (nm)
TLT $ 91.32 nm (nm)
GLD $ 378.20 $ -1.27 (-0.34 %)
$ 1.88
$ 1.89
$ 1.86 x 300
$ 1.89 x 14
$ 1.83 - $ 1.92
$ 1.42 - $ 38.50
58,982
na
14.16M
$ 1.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-15-2025 06-30-2025 10-K
2 05-12-2025 03-31-2025 10-Q
3 02-11-2025 12-31-2024 10-Q
4 11-13-2024 09-30-2024 10-Q
5 09-30-2024 06-30-2024 10-K
6 05-14-2024 03-31-2024 10-Q
7 02-12-2024 12-31-2023 10-Q
8 11-08-2023 09-30-2023 10-Q
9 08-16-2023 06-30-2023 10-K
10 05-12-2023 03-31-2023 10-Q
11 02-10-2023 12-31-2022 10-Q
12 11-04-2022 09-30-2022 10-Q
13 09-27-2022 06-30-2022 10-K
14 05-11-2022 03-31-2022 10-Q
15 02-08-2022 12-31-2021 10-Q
16 11-10-2021 09-30-2021 10-Q
17 08-30-2021 06-30-2021 10-K
18 05-10-2021 03-31-2021 10-Q
19 01-29-2021 12-31-2020 10-Q
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-K
22 05-13-2020 03-31-2020 10-Q
23 02-13-2020 12-31-2019 10-Q
24 11-19-2019 09-30-2019 10-Q
25 09-27-2019 06-30-2019 10-K
26 05-10-2019 03-31-2019 10-Q
27 02-12-2019 12-31-2018 10-Q
28 11-14-2018 09-30-2018 10-Q
29 10-05-2018 06-30-2018 10-K
30 05-14-2018 03-31-2018 10-Q
31 02-14-2018 12-31-2017 10-Q
32 11-08-2017 09-30-2017 10-Q
33 08-24-2017 06-30-2017 10-K
34 05-09-2017 03-31-2017 10-Q
35 02-07-2017 12-31-2016 10-Q
36 11-16-2016 09-30-2016 10-Q
37 09-28-2016 06-30-2016 10-K
38 05-23-2016 03-31-2016 10-Q
39 02-16-2016 12-31-2015 10-Q
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

biovie-to-present-poster-highlighting-design-and-enrichment-strategy-of-its-ongoing-phase-2-address-lc-trial-at-keystone-symposia
BioVie To Present Poster Highlighting Desi...
08/13/2025 20:13:17

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
08/08/2025 17:07:58

sp-500-moves-higher-under-armour-shares-tumble-after-q1-results
S&P 500 Moves Higher; Under Armour Shares ...
08/08/2025 16:46:34

dow-surges-300-points-american-axle--manufacturing-posts-upbeat-earnings
Dow Surges 300 Points; American Axle & Man...
08/08/2025 14:23:53

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/08/2025 12:08:44

why-expedia-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket
Why Expedia Shares Are Trading Higher By A...
08/08/2025 09:14:47

reported-earlier-biovie-prices-12m-public-offering-of-6m-units-consisting-of-common-stock-and-warrants-at-200-per-unit
Reported Earlier, BioVie Prices $12M Publi...
08/08/2025 07:22:21

Each unit is being sold to the public at a price of $2.00 per unit (and each pre-funded unit is being sold to the public at the...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/06/2025 17:06:59

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
07/21/2025 17:06:07

biovie-announces-data-highlighting-bezisterim-at-7th-world-aging-and-rejuvenation-conference
BioVie Announces Data Highlighting Beziste...
07/09/2025 12:10:39

biovie-to-implement-1-for-10-reverse-stock-split-effective-july-7-2025
BioVie To Implement 1-For-10 Reverse Stock...
06/27/2025 21:24:06

- SEC Filing

biovie-to-present-patient-centric-design-and-accessibility-of-ongoing-sunrise-pd-phase-2-clinical-trial-at-advanced-therapeutics-in-movement--related-disorders-congress
BioVie To Present Patient-Centric Design A...
06/26/2025 12:01:48

BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug ther...

biovie-to-present-decentralized-design-and-patient-experience-of-phase-2-sunrise-pd-clinical-trial-evaluating-bezisterim-in-early-parkinsons-disease-at-advanced-therapeutics-in-movement--related-disorders-congress
BioVie To Present Decentralized Design And...
06/24/2025 20:07:17

biovie-enrolls-first-patient-in-phase-2-address-lc-clinical-trial-evaluating-bezisterim-for-treatment-of-neurological-symptoms-associated-with-long-covid-expects-topline-data-to-be-available-in-h1-2026
BioVie Enrolls First Patient In Phase 2 AD...
05/15/2025 12:15:23

Despite growing recognition of long COVID as a serious condition, diagnosed patients have no approved treatment options, with m...

biovie-announces-it-will-present-rationale-and-design-of-phase-2-sunrise-pd-clinical-trial-at-30th-world-congress-on-parkinsons-disease-and-related-disorders-may-7-10-2025-in-new-york-city
BioVie Announces It Will Present Rationale...
05/07/2025 12:02:02

BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company") a clinical-stage company developing innovative drug ther...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
05/02/2025 21:05:50

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
05/02/2025 17:07:23

biovie-opens-patient-enrollment-for-phase-2-sunrise-pd-clinical-trial-evaluating-the-safety-and-efficacy-of-bezisterim-on-motor-and-non-motor-symptoms-in-patients-with-parkinsons-disease-who-havent-been-treated-with-carbidopalevodopa-topline-data-expected-in-late-2025-or-early-2026
Biovie Opens Patient Enrollment For Phase ...
04/16/2025 12:03:05

SUNRISE-PD evaluating the Company's anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson&...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
01/28/2025 12:06:29

biovie-to-present-design-of-planned-phase-2-study-of-bezisterim-for-the-treatment-of-long-covid-at-the-demystifying-long-covid-international-conference
BioVie To Present Design Of Planned Phase ...
11/20/2024 13:26:59

BioVie Inc. (NASDAQ:BIVI), ("BioVie" or the "Company"), a clinical-stage company developing innovative drug the...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION